Table 2 (abstract P25). Facilitators of spin in clinical studies evaluating performance of biomarkers in ovarian cancer
From: Methods for Evaluation of medical prediction Models, Tests And Biomarkers (MEMTAB) 2018 Symposium
Potential facilitators of spin | Spin frequency, n= 200 n (%) [95% CI] |
|---|---|
Not stating sample size calculations | 200 (100% [98% - 100%]) |
Not mentioning potential harms | 200 (100% [98% - 100%]) |
Not pre-specifying a positivity threshold for continuous biomarker | 84/164* (51.2% [43% - 59%]) |
Incomplete or not reporting imprecision or statistical test for data shown | 26 (13% [9% - 19%]) |
Study objective not reported or unclear | 24 (12% [8% - 18%]) |